GRI Bio, Inc. (GRI)
GRI Bio Market Cap : 3.324M for April 24, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| AIM ImmunoTech, Inc. | 1.774M |
| Akari Therapeutics Plc | 6.639M |
| Moleculin Biotech, Inc. | 5.237M |
| ACADIA Pharmaceuticals, Inc. | 3.746B |
| Agenus, Inc. | 150.14M |
Market Cap Related Metrics
| Price to Book Value | 0.5531 |
| Price | 2.30 |
| Earnings Yield | -3.64K% |